Priority Review Granted to Keytruda Combo for Endometrial Cancer
Keytruda plus chemotherapy has been granted a priority review by the FDA to treat certain patients with endometrial cancer.
Stay updated with breaking news from Ramez Eskander. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Keytruda plus chemotherapy has been granted a priority review by the FDA to treat certain patients with endometrial cancer.
The Foundation for Women's Cancer (FWC) is pleased to host a Patient and Advocate Education Forum on Friday, March 15, 2024, 10 a.m. – 4:30 p.m. PT, in San Diego, CA, at the San Diego Convention Center the day before the start of the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women's Cancer.
The Foundation for Women’s Cancer (FWC) is pleased to host a free Patient and Advocate Education Forum on Friday, March 15, 2024, 10 a.m. – 4:30 p.m.
Closing their conversation, Ramez Eskander, MD, and Krishnansu Tewari, MD, share how they envision the future treatment landscape for patients with advanced endometrial cancer.
Ramez Eskander, MD, presents the profile of a 64-year-old postmenopausal woman diagnosed with recurrent endometrial carcinoma for discussion.